InvestorsHub Logo
Followers 0
Posts 66
Boards Moderated 0
Alias Born 03/27/2013

Re: sts66 post# 128814

Wednesday, 05/23/2018 3:04:21 PM

Wednesday, May 23, 2018 3:04:21 PM

Post# of 426861
STS, This was from yesterday and I am not sure where I was going with it. There are other drugs that might be seen as safe until you get into a CVOT. Because of side effects over the long term what may be seen as a positive on the cardiology side can end up being negative because of the overall risk of the drug. Niacin would be one I would point out. I was just trying to say that Vascepa is safe and is effective for cardiovascular biomarkers. From what has been reported no deaths have been attributed to Vascepa from the FDA with Vascepa being the primary cause of death. As you have said, some thing get attributed to drugs that should not. What I was trying to get at from what I have seen is that the CVOTs that failed, failed because the drug was either unsafe to begin with or the drug did not have a positive impact on cardiovascular biomarkers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News